MONETTE: A Study of Ceralasertib Monotherapy and Ceralasertib Plus Durvalumab in Patients With Melanoma and Resistance to PD-(L)1 Inhibition
This trial aims to investigate how effective ceralasertib alone or the combination treatment of ceralasertib and durvalumab are at treating advanced melanoma in patients who have disease progression while receiving standard immunotherapy treatment.The trial also aims to look at how well patients cope with these treatments, for example, if they experience any side effects.Ceralasertib is a treatment that has been shown to be effective at treating different types of cancers in many clinical trials. [...]
Locations: Addenbrookes Hospital, The Royal Marsden Hospital (LONDON), Mount Vernom Hospital, The Royal Marsden Hospital (SURREY)